Artificial intelligence (AI) solutions have the potential to improve patient outcomes and streamline healthcare operations. DeLorean Artificial Intelligence’s CEO and founder, Severence MacLaughlin, discusses how the DeLorean AI solution predicts the onset of chronic diseases and recommends the next best action to improve patient health, how this solution supports value-based care and can help decrease costs and how to overcome challenges of adopting AI.

Learn more about:

• The accuracy of DeLorean AI’s predictions for chronic conditions such as kidney disease, diabetes and heart disease
• How AI can help lower care costs through early identification of chronic disease patients
• How to scale AI solutions enterprisewide and safeguard patient data